- |||||||||| Journal: A new lead to NLRP3 inhibition. (Pubmed Central) - Mar 27, 2019
We hypothesize that this effect may be mediated through the NLRP3 inflammasome activation. The discovery of a small molecule inhibitor that targets the inflammasome sensor NLRP3 offers a new path for the development of selective inflammasome blockers with potential therapeutic benefit in a wide range of human diseases (in this issue, see Jiang et al., https://doi.org/10.1084/jem.20171419).
- |||||||||| Journal: Microbial metabolite sensor GPR43 controls severity of experimental GVHD. (Pubmed Central) - Jan 8, 2019
The GVHD protective effect of SCFAs requires GPR43-mediated ERK phosphorylation and activation of the NLRP3 inflammasome in non-hematopoietic target tissues of the host. These data provide insight into mechanisms of microbial metabolite-mediated protection of target tissues from the damage caused allogeneic T cells.
- |||||||||| Biomarker, Observational data, Journal: Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study. (Pubmed Central) - Nov 27, 2018
Both mtROS and NLRP3 inflammasome play a role in ozone-induced lung inflammation while only NLRP3 is involved in ozone-induced emphysema. Our results underscore the pathobiological relevance of ASC specks and suggest that ASC specks are a sensitive and specific candidate plasma biomarker that provides an index of medullary pyroptotic cell death and ineffective haemopoiesis in patients with myelodysplastic syndromes.
|